Recruiting

Tele-Education

Sponsor:

University of Florida

Code:

NCT07417865

Conditions

Diabetes

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

ECHO Diabetes tele-education

Study Details

Brief summary:

Extension for Community Health Outcomes Diabetes FQHC will provide tele-education to primary care providers (PCP) in Federally Qualified Health Centers in the U.S. using the "hub" and "spoke" training model established in the Project ECHO model. Participating FQHCs (called "spokes") will receive twice monthly tele-education sessions delivered by UF's "hub" team in a 6-month program. The program will be evaluated using pre/posttest provider-level surveys and center-level aggregate data in a stepped-wedge trial design with 3 cohorts of FQHCs. The primary outcomes are the proportion of people >9% HbA1c and technology use (CGM and insulin pump).

Conditions

Diabetes

Study ID

NCT07417865

Start date

Jan 22, 2026

Status verified date

Jan, 2026

Completion date

Jul 31, 2028

Anticipated

Primary completion date

Jul 31, 2028

Anticipated

Eligibility Criteria

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Inclusion Criteria: Federally Qualified Health centers (spokes) are eligible to participate that are part of Health Choice Network (HCN) or Alliance Chicago (AC). All people living with diabetes 18 and older are included in aggregate data sharing to evaluate outcomes.

\-

Exclusion Criteria:

  • Non FQHC, not part of HCN or AC

Study Design

Enrollment

18 participants

Anticipated

Interventions and Outcome Measures

Arms

Cohort 1

6-8 Federally Qualified Health Centers that participate in the ECHO Diabetes tele-education program for PCPs

Cohort 2

6-8 Federally Qualified Health Centers that participate in the ECHO Diabetes tele-education program for PCPs

Cohort 3

6-8 FQHCs that participate in the ECHO Diabetes tele-education program for PCPs

Interventions

ECHO Diabetes tele-education

All cohorts will be given the ECHO Diabetes tele-education program -- one hour sessions twice monthly for 6 months for PCP in FQHCs

Primary outcome measure

  • HEDIS >9% HbA1c [ Time Frame: From baseline to 12-months following ]
  • Technology Use [ Time Frame: From baseline to 12-months following ]

Central Contacts and Locations

Central contacts

Ashby F Walker, Ph.D.

352-273-8278afwalker@ufl.edu

Locations

Health Choice Network

Recruiting

Miami, Florida, United States, 33172

Contacts

Crystal Walker, RMA, CPC

305-392-8093Crwalker@hcnetwork.org

Alliance Chicago

Recruiting

Chicago, Illinois, United States, 60654

Contacts

Dana Bright, MSW

312-274-0068dbright@alliancechicago.org

More Information

Sponsor

University of Florida

Last update posted

Feb 18, 2026

Last verified

Jan, 2026

Keywords

  • ECHO

Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-09. This information was provided to ClinicalTrials.gov by University of Florida on 2026-02-18.